Table 2 Study characteristics of the included studies
From: Quality of life instruments in atrial fibrillation: a systematic review of measurement properties
Instrument | Authors | Years | Country | Language | N | Mean age | Gender (% female) | Type of AF (%) |
|---|---|---|---|---|---|---|---|---|
AFEQT [39] | Spertus et al. | 2011 | USA, Canada | English | 214 | 62 ± 11.9 | 42.50% | 66% paroxysmal, 24% persistent, 5% longstanding persistent, 5% permanent |
AFEQT [40] | Dorian et al. | 2013 | USA, Canada | English | 214 | 62 ± 11.9 | 42.50% | 66% paroxysmal, 24% persistent, 5% longstanding persistent, 5% permanent |
AFEQT [41] | Tailachidis et al. | 2016 | Greece | Greek | 102 | 70 ± 9.2 | 46.10°% | 59.8% permanent; 31.4% persistent; 8.8% paroxysmal |
AFEQT [42] | Holmes et al. | 2019 | USA | English | 1347 | 74 ± 9.8 | 43°% | 8.2% first detected; 48.8% paroxysmal; 13.4% persistent; 29.6% permanent |
AFEQT [43] | Gune§ et al. | 2021 | Turkey | Turkish | 204 | 71.33 ± 10.34 | 65.2 | 88.2% permanent |
AFEQT [44] | Li et al. | 2021 | Hong Kong | Chinese | 200 | 69.8 ± 5.2 | 48.50% | 44.5% paroxysmal; 52.5% undifferentiated; 1% persistent; 1% permanent |
AFSS[45] | Dorian et al. | 2002 | Canada | English | 161 | 58 ± 12 | 31°% | 54% paroxysmal; 35% persistent; 11% permanent |
AFSS[46] | Kahya Eren et al. | 2014 | Turkey | Turkish | 130 | 63.1 ± 10.9 | 41.50% | 30% paroxysmal; 6.2% persistent; 63.8% permanent |
SCL [38] | Berkowitsch et al. | 2003 | Germany | N/A | 60 | 58 ± 11 | 35% | 100% paroxysmal refractory to > 3 AADs |
SCL[47] | Bubien et al. | 1996 | USA | English | 159 | 49 ± 15.8 | 56% | 13.8% atrial fibrillation; 86.2% other arrhythmias |
SCL [48] | Carnlof et al. | 2020 | Sweden | Swedish | 646 | 61.4 ± 1.5 | 50% | 52.3% atrial fibrillation; 47.7% other arrhythmias |
AFQLQ [49] | Moreira et al. | 2016 | Brazil | English | 40 | 61.2 ± 9.6 | 35% | 47.5% persistent; 52.5% permanent |
ASTA [50] | Walfridsson et al. | 2015 | Sweden | Swedish | 270 | 59.3 ± 13 | 34% | 67% AF; 33% other arrhythmias |
ASTA [51] | Lomper et al. | 2019 | Poland | Polish | 244 | 70.7 ± 10.7 | 56.60% | 47.5% paroxysmal; 52.5% permanent/persistent |
ASTA [52] | Cannavan et al. | 2020 | Brazil | Portugese | 140 | 57.2 ± 13.1 | 55% | 50.71% AF; 49.29% other arrhythmias |
MLHF-Q [53] | Middel et al. | 2001 | Netherlands | Dutch | 60 | 61.5 ± 12.7 | 35% | Type of AF not specified |